Study Shows Promise For New Drug To Treat Fragile X

Monday, Jan. 24th 2011 6:24 AM

The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in the larger follow-up clinical trial.

Posted on Monday, Jan. 24th 2011 6:24 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.